Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study.

Autor: Eng, Grith Petersen1,2,3 eng@dadlnet.dk, Bouchelouche, Pierre1, Bartels, Else Marie3, Bliddal, Henning3, Bendtzen, Klaus4, Stoltenberg, Michael2
Zdroj: PLoS ONE. 9/8/2016, Vol. 11 Issue 9, p1-12. 12p.
Databáze: Academic Search Ultimate